Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial

Ascierto, Paolo A.; McArthur, Grant A.; Dreno, Brigitte; Atkinson, Victoria; Liszkay, Gabrielle; Di Giacomo, Anna Maria; Mandala, Mario; Demidov, Lev; Stroyakovskiy, Daniil; Thomas, Luc; de la Cruz-Merino, Luis; Dutriaux, Caroline; Garbe, Claus; Yan, Yibing; Wongchenko, Matthew; Chang, Ilsung; Hsu, Jessie J.; Koralek, Daniel O.; Rooney, Isabelle; Ribas, Antoni; Larkin, James

Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial

Autor(en):

Ascierto, Paolo A.; McArthur, Grant A.; Dreno, Brigitte; Atkinson, Victoria; Liszkay, Gabrielle; Di Giacomo, Anna Maria; Mandala, Mario; Demidov, Lev; Stroyakovskiy, Daniil; Thomas, Luc; de la Cruz-Merino, Luis; Dutriaux, Caroline; Garbe, Claus; Yan, Yibing; Wongchenko, Matthew; Chang, Ilsung; Hsu, Jessie J.; Koralek, Daniel O.; Rooney, Isabelle; Ribas, Antoni; Larkin, James

Tübinger Autor(en):

Garbe, Claus

Erschienen in:

Lancet Oncology (2016), Bd. 17, H. 9, S. 1248-1260

Verlagsangabe:

Elsevier Science Inc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/S1470-2045(16)30122-X

ISSN:

1474-5488